Qualification of novel methodologies for medicine development: CHMP qualification opinions

Qualification of novel methodologies for medicine development: CHMP qualification opinions The European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) issues qualification opinions on novel methodologies for medicine development. These opinions confirm their validity in specific contexts of use for generating evidence to support regulatory decision-making. Human Regulatory and procedural guidance Research and development